The Return Of The US Pharma Sales Force
Executive Summary
The number of pharmaceutical sales reps in the US grew to the highest levels in 2016 since 2011. The trend has continued in 2017, fueled by growth in oncology, where there have been new launches.
You may also be interested in...
DTC Advertising Is Back With A Bang
The pharmaceutical industry spent roughly $6bn in 2015 on direct-to-consumer advertising, and the upswing is expected to continue due to favorable economics. Most of the dollars go to TV ads, with more emphasis on targeted patient groups.
U.S. Promo Spend Continued To Fall In 2012
Pharmaceutical promotional spend in the U.S. has dropped steeply over the last five years as companies have cut their sales forces, causing the number of office visits to drop and sampling to decline.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.